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Body size and thyroid nodules in healthy Korean 
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Purpose: Excess weight and obesity have been associated with numerous diseases including thyroid cancer, but the relation-
ship has been weak. The objective of this study was to evaluate the relationship of body sizes on thyroid nodules in healthy 
Korean population. Methods: A total of 7,763 persons who underwent a health examination in our health examination center 
were included in this study. The epidemiologic factors, body size and thyroid ultrasound results were reviewed. We inves-
tigated the effects of body size on the presence of thyroid nodules and malignancy. Results: The incidence of thyroid nodules 
was 20.6%. In the group who were found to have thyroid nodules, mean height, weight and body surface area (BSA) were 
significantly smaller compared to the others. Especially, in the women, smaller height (less than 160 cm) and overweight (≥
60 kg) were identified as independent risk factors for the presence of thyroid nodules. The patients with body mass index 
(BMI) subgroups of normal or overweight had a tendency to have thyroid nodules more frequently. The detection rate of thy-
roid cancer was 0.47%. The patients with thyroid cancer tended to be smaller in height and BSA than the others. Conclusion: 
A higher frequency of thyroid nodules was associated with women and, older age. In women, there were significant correla-
tions in height, weight and BMI subgroups to the presence of thyroid nodules.
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INTRODUCTION
Excess weight and obesity have been associated with an 
increased risk of musculoskeletal disorders, hypertension, 
diabetes, cardiovascular disease, and metabolic syndrome 
[1]. And they are also associated with a high risk of some 
common adult cancers, including thyroid cancer [2]. Positi 
ve associations between height, weight and body mass in-
dex (BMI) and thyroid cancer have been reported in large 
prospective studies and meta-analysis, but these associa-
tions generally have been weak and have not always been 
consistent across studies [3-7]. Most of these studies have 
looked into the association within Caucasians, and studies 
on Asian are insufficient. Recently, Suzuki et al. [8] re-
ported the anthropometric factors which had effected on 
the risk of thyroid cancer. In that study, they showed a pos-
itive association between current weights, weight at age 20 
years and height, and thyroid cancer risk. 
The frequency of obesity has recently been increasing in 
Korea, although it is not as frequent as with Caucasians. Ju-Yeon Kim, et al.
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Table 1. Comparisons between patients with or without thyroid nodules
Variable Non-nodular group (n = 6,160) Nodular group (n = 1,603) P-value
Sex (M：F) 3,930：2,230 751：852 ＜0.001
Mean age (yr) 45.35 ± 10.38 49.58 ± 10.91
  ＜45 3,027  (49.1) 517  (32.3) ＜0.001
  ≥45  3,133 (50.9) 1,086 (67.7) ＜0.001
Body size
  All patients
    Height (cm) 166.59 ± 8.37 163.84 ± 8.75 ＜0.001
    Weight (kg) 66.27 ± 11.24 64.17 ± 10.75 ＜0.001
    BSA (m
2) 1.75 ± 0.18 1.71 ± 0.18 ＜0.001
    BMI (kg/m
2) 23.78 ± 2.96 23.82 ± 2.85     0.688
  Male/Female
    Height (cm) 171.16 ± 5.89/158.53 ± 5.53 170.82 ± 5.84/157.69 ± 5.76 0.137/＜0.001
    Weight (kg) 71.31 ± 9.70/57.21 ± 7.53 71.28 ± 9.38/58.01 ± 7.49 0.946/0.034
    BSA (m
2) 1.839 ± 0.144/1.588 ± 0.117 1.837 ± 0.139/1.590 ± 0.116 0.383/0.004
    BMI (kg/m
2) 24.31 ± 2.81/22.85 ± 2.98 24.40 ± 2.74/23.30 ± 2.84 0.670/0.112
Values are presented as mean ± standard deviation or number (%).
BSA, body surface area; BMI, body mass index.
Usually Koreans have the enough iodine nutrition and the 
incidence of thyroid cancer has been increased sharply in 
recent, so studies on Koreans are needed. Hence, the au-
thors investigated the effects of height, weight and BMI on 
thyroid nodules for healthy people. 
METHODS
The subjects of this study were persons who underwent 
a health examination from January 2009 to December 2009 
in health examination in Gyeongsang National University 
Hospital. Twenty-five patients who had other underlying 
malignancies and an operation history of the thyroid were 
excluded from the subjective group. 
The epidemiologic factors and body size were de-
termine based on records of health examinations, and BMI 
and body surface area (BSA) were calculated according to 
their determined formula (i.e., BMI = weight (kg)/height 
(m)
2, BSA =   × ). The BMI results were 
categorized using the World Health Organization classi-
fication; BMI ＜18.5 benign considered underweight; 18.5 
to 24.9, normal; 25 to 29.9, overweight; and ＞30, obese [9]. 
All the persons who received health examinations un-
derwent neck ultrasonography, and when a thyroid nod-
ule was discovered, the existence of a fine needle aspira-
tion (FNA) was determined in accordance with the 
Aemerican Thyroid Association guideline [10]. 
All data are expressed as mean ± standard deviation. 
The SPSS ver. 15.0 (SPSS Inc., Chicago, IL, USA) was used 
for statistical analysis. A P-value less than 0.05 was consid-
ered statically significant. 
RESULTS
A total of 7,763 persons were studied; 4,681 men, and 
3,082 women. The mean age was 46.22 ± 10.63 years, and 
mean BMI was 23.79 ± 2.94 kg/m
2. The overall prevalence 
of each BMI category was as follows; 2.7% were under-
weight, and 65.0% were normal, 29.8% were overweight 
and 2.5% were obese. The number of subjects who were 
found to have a thyroid nodule was 1,603 (20.6%), and a 
FNA was performed to 1,402 subjects. Among those who 
underwent FNA, 37 (2.31%) of those who had a thyroid 
nodule were found to be malignant, and 1,365 subjects 
were found to be benign. 
Characteristic by the existence of thyroid nodules
In the group who were found to have thyroid nodules, 
the percentage of women was 53.2%; higher than that of 
men and the mean age of the patients with thyroid nodule Body size and thyroid nodules
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Table 2. The associations between body size and presence of 
thyroid nodule in females
Variable
Nodular group 
(n = 852)
Odds 
ratio
P-value
 Height 0.001
   ＜160 cm  536/1,894 (29.7) 1.33
   ≥160 cm  316/1,278 (24.7)
 Weight 0.006
   ＜60 kg  549/2,074 (26.5)
   ≥60 kg 303/1,008 (30.1) 1.267
 BSA 0.431
   ＜1.55 m
2 316/1,178  (26.8)
   ≥1.55 m
2 536/1,904  (28.2) 1.02
 BMI group 0.039
   Normal or overweight 810/2,880 (28.12) 1.448
   Underweight or obese      42/202 (20.79)
Values are presented as number (%).
BSA, body surface area; BMI, body mass index.
Table 3. The characteristics of the patients with thyroid cancer
Characteristic Malignant group (n = 37) Others (n = 7,726) P-value
Sex (M：F)   14：23 (37.8：62.2) 4,467：3,059 (37.8：62.2) 0.007
Mean age (yr) 47.46 ± 12.11 47.46 ± 12.11 0.287
  ＜45  15 (40.5)   3,529 (45.7) 0.621
  ≥45  22 (59.5)   4,197 (54.3)
Body size
  All patients
    Height (cm) 161.74 ± 8.40 166.04 ± 8.50 0.002
    Weight (kg) 62.91 ± 10.31 65.85 ± 11.17 0.110
    BSA (m
2) 1.68 ± 0.17 1.74 ± 0.18 0.037
    BMI (kg/m
2) 23.97 ± 3.05 23.79 ± 2.93 0.703
  Male/Female
    Height (cm) 167.69 ± 4.14/157.96 ± 8.12 172.12 ± 5.89/158.30 ± 5.58 0.014/0.772
    Weight (kg) 71.51 ± 6.69/57.68 ± 8.48 71.30 ± 9.66/57.54 ± 7.66 0.908/0.932
    BSA (m
2) 1.825 ± 0.098/1.587 ± 0.142 1.839 ± 0.143/1.588 ± 0.116 0.623/0.960
    BMI (kg/m
2) 25.35 ± 2.28/23.14 ± 3.19 24.32 ± 2.80/22.98 ± 2.94 0.115/0.800
Values are presented as number (%) or mean ± standard deviation.
BSA, body surface area; BMI, body mass index.
was also higher (P = 0.000). In the women, the mean height, 
weight and BSA of the group who were found to have thy-
roid nodules were significantly smaller compared to the 
others. But there were no statistical differences for the 
body sizes in the men (Table 1).
In the women, 852 (27.64%) people had thyroid nodules. 
When we compared the rate of thyroid nodules according 
to their body sizes (Table 2), the height less than 160 cm 
and weight more than 60 kg were identified the significant 
risk factors of thyroid nodules (odds ratio, 1.33 and 1.267). 
Also the patients who were normal or overweight in BMI 
subgroup were identified to have higher frequency of thy-
roid nodules. However, we could not find the significant 
relationship between body sizes and thyroid nodule in the 
men.
Characteristics by the existence of malignant nod-
ules
Among the subjects, malignant cases were 37 (0.47%) of 
the total (0.28% of men and 0.74% of women). The patients 
who were concluded with thyroid cancer had significantly 
smaller mean height and BSA than the others. At the anal-
ysis according to sex, however, the height of men was the 
only significant factor to the existence of malignant nod-
ules of thyroid (Table 3).
DISCUSSION
Thyroid nodule is one of the most common diseases 
originating from the endocrine systems. When thyroid 
nodules discovered through thyroid ultrasonography are 
included as well as clinically palpable thyroid nodules, the 
prevalence of thyroid nodules has been reported as 14 to 
41% [11-14]. It has been reported that thyroid nodules in-
crease with age and their frequency is higher among Ju-Yeon Kim, et al.
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women. When neck ultrasonography was performed for 
healthy persons with no symptoms in this study, the fre-
quency of thyroid nodules was 20.6%, and tended to be 
higher among women and increase with age. When the 
correlation between body size and thyroid nodule was ex-
amined, however, the group who were found to have thy-
roid nodules were smaller in height, weight and BSA (P = 
0.000). The older persons tended to have smaller height 
and weight, but the multivariate analysis found that 
height had statistical significance. 
Most thyroid nodules are benign tumors. However, 5 to 
15% were reported as malignant, and it is a clinically im-
portant task to differentiate them. It has been reported that 
the frequency of malignancy increases among persons 
aged under 20 or persons aged 60 or over. An association 
with a history of radiation exposure has been also found 
[11-13]. The detection rate of thyroid cancer in health exam 
was 0.47%, which was very low compared to another 
studies. So we could not find the significant cut-off values 
of the body sizes effecting to thyroid cancer. 
Thyroid nodule is one of the most common diseases 
originating from the endocrine systems. Recently many 
studies on the correlations between thyroid cancer and 
height, weight, and BMI have been published. A study by 
Iribarren et al. [14] reported that there were no correlations 
between thyroid cancer and height, weight, or BMI. Dal 
Maso et al. [15] reported only a weak correlation between 
thyroid cancer and height. According to a large-scale 
study on Norwegians in England, higher BMI or height in-
creased the frequencies of papillary thyroid cancer and 
follicular cancer among both men and women a little, and 
the opposite tendency was observed for medullary cancer 
[3]. Renehan et al. [2] conducted a meta-analysis of five 
prospective studies on thyroid cancer and BMI, and re-
ported that the risk of thyroid cancer for each increase of 5 
in BMI among men and women were 1.52 and 1.14, 
respectively. According to a study by Sung et al. [16] on the 
development of various cancers by height, the greater the 
height, the higher the frequency of thyroid cancer became 
for both men and women. According to the hypotheses 
about these correlations, the increase of fat is associated 
with the increase of insulin which also affects an insulin- 
like growth factor, and this increases the development of 
cancer. Another hypothesis postulates that an increase in 
sex hormones is associated with the increasing develop-
ment of cancer among women. Yet another hypothesis 
claims that people with greater height or BMI tend to have 
larger organs which increase the likelihood of cancerous 
developments of cells [15-20].
This study has a limitation in that it compared body in-
dexes at a certain point of time depending on the existence 
of cancer rather than investigating the frequency of cancer 
through follow-up. According to a study in 2000 which an-
alyzed 12 case-control studies and compared the height, 
weight and BMI of subjects at the time of diagnosis of thy-
roid cancer with those of the control group, the group who 
were diagnosed as having thyroid cancer showed higher 
indexes among women, but no significant differences 
were found among men, and there were large differences 
regarding this between studies [15]. This study also found 
no statistically significant differences between the benign 
group and the malignant group who were found from 
health examination. 
Mijović et al. [17] conducted a study on patients with 
thyroid nodules and indeterminate significance on FNA 
reported that the higher the BMI was, the lower the malig-
nancy rate was except for women aged 45 or older. 
Although the subjects are different, the underweight and 
obese groups in this study showed a higher malignancy 
rate, although there was no statistical significance. 
In this study, the percentage of thyroid nodules among 
healthy persons discovered from health examination was 
20.6%. A higher frequency of thyroid nodules was asso-
ciated with women, older age. In the women, the height 
less than 160 cm and the overweight (≥60 kg) were sig-
nificantly associated with the presence of thyroid nodules. 
And the patients with normal or overweight of BMI sub-
group had tendency more frequent thyroid nodules than 
others. The detection rate of thyroid cancer was 0.47%. The 
patients with thyroid cancer were founded to have smaller 
mean values in height and BSA. But we could not find the 
significant factors of body sizes which might influence the 
development of the thyroid cancer. More cases are needed 
to identify the risk factors of thyroid cancer.Body size and thyroid nodules
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